Bristol-Myers Squibb

Release Summary

Advaxis and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate ADXS-DUAL and Opdivo (nivolumab) in Metastatic Cervical Cancer

Bristol-Myers Squibb